ProfileGDS5822 / ILMN_2810405
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 69% 77% 71% 69% 70% 69% 61% 68% 73% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 145.469
GSM1276600PDAC Late Ablation Control 2105.277
GSM1276601PDAC Late Ablation Control 380.371
GSM1276602PDAC Late Ablation 142.669
GSM1276603PDAC Late Ablation 257.870
GSM1276604PDAC Late Ablation 352.469
GSM1303940PDAC Late Ablation_anti-CTLA4 129.261
GSM1303941PDAC Late Ablation_anti-CTLA4 259.168
GSM1303942PDAC Late Ablation_anti-CTLA4 389.573